The immunohistochemistry (IHC) market is on a promising growth trajectory, with an anticipated value of USD 3.5 billion in ...

Astellas Pharma today announced that the US Food and Drug Administration (FDA) has approved VYLOY (zolbetuximab-clzb) in ...

Wood stain can bring new life to old or unfinished furniture. Staining wood furniture offers an opportunity to update and alter the appearance of favorite wood pieces to suit your room’s decor ...

RxDx Assay to identify patients with gastric or GEJ cancer gets CE Mark approval: Basel Friday, October 11, 2024, ...

The best carpet stain removers can be a lifesaver. Many of us have been there, and witnessed that moment when time slows down and a glass of red wine tumbles and splashes across your light carpet.

VYLOY is the first and only CLDN18.2-targeted treatment approved in the U.S. for adults with advanced gastric and gastroesophageal junction cancer whose tumors are CLDN18.2 positive TOKYO, Oct. 18 ...

The IHC companion diagnostic test determines CLDN18 protein expression and may help identify patients who are eligible for treatment with Vyloy.

The sBLA is supported by results from the phase IIIDESTINY-Breast06 trial (NCT04494425), which showed that patients with HER2 ...

ISLAMABAD: As daily life is paralysed in Islamabad as the PTI workers clashes with police continued for the second day on Saturday, the Islamabad High Court (IHC) has directed local authorities to ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved VYLOY™ (zolbetuximab-clzb) in combination ...